Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances

NCT04934774 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

T-cell Acute Lymphoblastic Leukemia
T-cell Acute Lymphoblastic Lymphoma
T-cell Non-Hodgkin Lymphoma

Interventions

BIOLOGICAL: CD7 CAR T cells

Sponsor

iCell Gene Therapeutics

Collaborators

[object Object]
[object Object]